Frontiers | How Should We Classify Kawasaki Disease?
Searching for the cause of Kawasaki disease — cytoplasmic inclusion bodies provide new insight | Nature Reviews Microbiology
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation
Recurrence of Fever After Initial Intravenous Immunoglobulin Treatment in Children With Kawasaki Disease - Masanori Yoshida, Shinji Oana, Hiroshi Masuda, Akira Ishiguro, Hitoshi Kato, Shuichi Ito, Tohru Kobayashi, Jun Abe, 2018
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Clinical Practice Guidelines : Kawasaki disease
Frontiers | Severe Recurrent Fever Episodes With Clinical Diagnosis of Hemophagocytic Lymphohistiocytosis, Incomplete Kawasaki Disease and Systemic-Onset Juvenile Idiopathic Arthritis: A Case Report and Literature Review
Children | Free Full-Text | Recurrent Kawasaki Disease: A Case Report of Three Separate Episodes at >4-Year Intervals
Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan | Archives of Disease in Childhood
![PDF] Recurrent Kawasaki disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/aa3a394f511eb113de41030fcbbefdfba677a432/2-Figure1-1.png "PDF] Recurrent Kawasaki disease. | Semantic Scholar")
PDF] Recurrent Kawasaki disease. | Semantic Scholar
Children | Free Full-Text | Efficacy of Anakinra on Multiple Coronary Arteries Aneurysms in an Infant with Recurrent Kawasaki Disease, Complicated by Macrophage Activation Syndrome
Frontiers | How Should We Classify Kawasaki Disease?
Late Treatment and Recurrence of Kawasaki Disease in a Moroccan Infant
Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature | Italian Journal of Pediatrics | Full Text
A case of recurrent Kawasaki disease
Frontiers | The Epidemiology and Pathogenesis of Kawasaki Disease
Associations between the spatiotemporal distribution of Kawasaki disease and environmental factors: evidence supporting a multifactorial etiologic model | Scientific Reports
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Recurrent Kawasaki Disease-Like Syndrome in a Patient with Acquired Immunodeficiency Syndrome
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Clinical characteristics of patients with recurrent Kawasaki disease: a nationwide cohort study of 19 456 patients with minimum 3-year follow up | Archives of Disease in Childhood
